Clinical Trial Update: MISHA Post-Market Clinical Study [NA]

View source ↗

Summary

MISHA post-market clinical study by Moximed is currently recruiting participants for osteoarthritis of the knee.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• MISHA

Snippet

Sponsor: Moximed | Conditions: Osteo Arthritis Knee | NA | Status: RECRUITING